جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

15 مُخرَج نتائج البحث عن «Nucleus»

مقالوصول مفتوح2026

Nrf2–Keap1 Signaling in Arthritis: Therapeutic Potential of Nanoparticle-Based Approaches with Special Reference to Silver Nanoparticles

International Journal of Clinical and Medical Research · مجلد 3 (1) · 34-39

Arthritis represents a heterogeneous group of inflammatory and degenerative joint disorders characterized by persistent inflammation, oxidative stress, cartilage degradation, synovial dysfunction and progressive impairment of joint integrity. Rheumatoid Arthritis (RA) and Osteoarthritis (OA), although distinct in etiology, share several pathological mechanisms involving excessive production of Reactive Oxygen Species (ROS), mitochondrial dysfunction, inflammatory cytokine activation and dysregulation of redox-sensitive signaling pathways [1-4]. The nuclear factor erythroid 2-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1 (Keap1) pathway is a major endogenous defense mechanism responsible for maintaining cellular redox homeostasis. Under basal conditions, Keap1 promotes Nrf2 degradation; however, oxidative or electrophilic stress disrupts this interaction, allowing Nrf2 to accumulate and translocate into the nucleus, where it activates antioxidant response element (ARE)-dependent genes, including heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione-related enzymes [5,6]. Increasing evidence indicates that impaired or insufficient Nrf2 activity contributes to persistent oxidative stress and inflammation in arthritic joints [1,7]. Nrf2 also interacts with major inflammatory pathways, particularly nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK) and NLRP3 inflammasome signaling [8]. Nanotechnology offers an opportunity to improve the delivery, stability, bioavailability and tissue targeting of therapeutic agents capable of modulating redox and inflammatory pathways. Among different nanomaterials, silver nanoparticles (AgNPs) have attracted considerable interest because of their antimicrobial, anti-inflammatory, antioxidant and immunomodulatory properties [9-11]. Experimental studies have demonstrated that AgNPs can reduce inflammatory cytokines, regulate NF-κB and MAPK signaling, influence macrophage polarization and alleviate inflammatory tissue injury [9,10]. In experimental RA, targeted folic-acid-modified AgNPs have demonstrated the ability to interact with inflammatory macrophages, promote macrophage apoptosis and repolarization and reduce disease severity [12]. Nevertheless, the relationship between AgNP exposure, oxidative signaling and Nrf2-Keap1 activation is complex and excessive nanoparticle-induced oxidative stress may also produce adverse biological effects. This review examines the role of the Nrf2-Keap1 pathway in arthritis, evaluates nanoparticle-based strategies for modulating redox and inflammatory mechanisms and critically discusses the therapeutic potential and safety considerations of AgNPs. Particular emphasis is placed on the potential intersection between AgNP-mediated redox regulation, Nrf2-Keap1 signaling, NF-κB inhibition, macrophage polarization and joint protection.

Nrf2/Keap1 pathwayarthritisrheumatoid arthritisosteoarthritis
مقالوصول مغلق2026

Effect of Polyvinyl Chloride and Polystyrene Micro‐Plastics on Growth, Digestive Enzymes, Oxidative Stress, and DNA Damage in Ctenopharyngodon idella

Journal of Applied Toxicology

Micro-plastics (MPs) have become a constant source of pollution in freshwater bodies and increasingly becoming a threat to aquatic life. Chronic exposure to MPs has been linked to the inhibition of growth, deformations in digestive physiology, oxidative stress, and cellular injury. Current study was conducted on fish (Ctenopharyngodon idella) acclimatizing and exposing them to a 90-day dietary exposure to MPs. The growth performance indicators, that is, digestive enzymes, oxidative stress biomarkers, and DNA damages were measured in the pre- and post-dietary exposure to the MPs. There was a progressive decrease in the growth performance indicators such as highest increase in weight as found in 30% PVC group (6.95 ± 2.69 g) and the 30% PS group (2.91 ± 3.28 g) was far less as compared to the corresponding controls (18.8 ± 5.86 and 16.07 ± 5.32 g, respectively). The levels of catalase activity in the control fish kidney, skin, heart, brain, and gill tissues were significantly higher than in the exposed groups (p < 0.05), whereby superoxide dismutase activity were increased, an indication to the increased oxidative stress. Digestive enzyme reactions were tissue-specific, where lipase was the most sensitive, mainly in the stomach and liver, at the increased dosage. The frequency of micronuclei also increased in the erythrocytes of exposed fish, which proves that polymers caused concentration-dependent genotoxic damage. Hence, PVC and PS MPs had negative effects on C. idella whereby growth was affected, antioxidant status was disturbed, genotoxicity was augmented, digestive enzyme biomarkers were affected, and micro-nucleus frequency was increased. Further research is required on chronic exposure, histopathological changes, and the mechanisms of MPs toxicity at the molecular level.

microplasticspolyvinyl chloridepolystyrenegrass carp
مقالمفتوح (مستودع)20252استشهاد· Semantic Scholar

LPS mediated neuronal c-Fos activation: whole-brain mapping, site and time effect in intoxicated mice

Toxicology Research · مجلد 14 (4) · tfaf131-tfaf131

Lipopolysaccharide (LPS; a bacterial endotoxin) treatment causes acute inflammatory conditions. Acute inflammation causes the brain to activate neurons in some brain nuclei known as circumventricular organs. The c-Fos immunoreaction could be used to assess this neural activity. The current study aimed to check the activated neurons in time and site effect during toxicity and inflammation induced by LPS. The c-Fos antibody immunofluorescence labeling was checked at one, three, and six hours after LPS intoxication. Moreover, a retrograde viral tracing approach was employed to verify the neuronal connections among certain brain nuclei that were activated. The results indicated the activation of several brain nuclei in the hippocampus, epithalamus, thalamus, hypothalamus, basal ganglia, midbrain, and medulla oblongata. The type of brain nuclei and the number of neurons that were activated in relation to the duration of acute inflammation were clearly different. Furthermore, this research demonstrated that these active brain nuclei were connected neuronally. Ultimately, acute inflammatory responses induced by LPS treatment activated dorsal raphe serotonergic neurons. Twenty-two brain nuclei were shown to be involved in the neuroinflammatory response via whole-brain mapping. One hour after LPS administration, neurons in the dorsomedial hypothalamic nucleus (DM), lateral septal nucleus (LS), and solitary tract nucleus (SOL) were significantly activated. However, the sensory circumventricular organs (CVOs) were activated three hours after LPS treatment. It was also demonstrated that dorsal raphe serotonergic neurons play a vital role in the body's reaction to acute inflammation. This study confirmed the involvement of dorsal raphe serotonergic neurons in response to acute inflammation and toxicity induced by LPS.

lipopolysaccharideneuroinflammationc-fosneuronal activation
مراجعةوصول مفتوح20251استشهاد· Semantic Scholar

Machine Learning for Prediction and Identification of Genetic Variants and Biomarkers in Autism Spectrum Disorder: A Systematic Review

Journal of Disability Research · مجلد 4 (6)

Autism spectrum disorder (ASD) is a diverse neurodevelopmental condition with a significant genetic basis. Machine learning (ML) and deep learning (DL) models are emerging as powerful tools for identifying potential ASD risk genes and biomarkers to improve diagnostic accuracy. This narrative systematic review synthesizes evidence on the use of ML and DL models for ASD prediction and diagnosis, focusing on studies that utilized genetic variants and biomarkers. We conducted a systematic search across six databases [Web of Science, PubMed, Science Direct, Semantic Scholar, Institute of Electrical and Electronics Engineers (IEEE Xplore), and Association for Computing Machinery Digital Library (ACM-DL)] for articles published between 2009 and 2024, yielding 483 initial records. Multiple inclusion criteria were applied, and only peer-reviewed articles that used artificial intelligence, ML, or DL to predict ASD based on genetic biomarkers were included. After deduplication and applying inclusion and exclusion criteria, 14 studies were included in this review. These studies focused on genetic variants based on whole-genome sequencing, whole-exome sequencing, RNA sequencing, single-nucleus RNA sequencing, mRNA expression, long non-coding RNA, or single nucleotide polymorphism data. Our findings indicate that various ML models achieved robust performance, while DL architectures such as DeepASDPred outperformed ML models, with an accuracy of 93.8%. Most of the studies used datasets such as the Simons Foundation Autism Research Initiative (SFARI), the Simons Simplex Collection (SSC), the Autism Genetic Resource Exchange (AGRE), Atlas of the Developing Human Brain (BrainSpan), and the Simons Foundation Powering Autism Research for Knowledge (SPARK). The reviewed studies demonstrate that ML can help identify genetic risk factors and biomarkers that contribute to ASD. However, challenges remain, including data heterogeneity, small sample sizes, and the need for greater model interpretability. Addressing these challenges is crucial for translating ML models into clinically useful tools. In conclusion, DL substantially enhances ASD prediction, leveraging genetic data to identify novel candidate genes and support biological discovery of cell type-specific gene expression and roles of non-coding mutations in ASD.

autism spectrum disordermachine learningdeep learninggenetic variants
مقالوصول مفتوح2025

Subcortical substructure abnormalities in idiopathic generalized epilepsy (IGE) patients: MRI volumetric study

Journal of Radiation Research and Applied Sciences · مجلد 18 (3) · 101735-101735

Background Idiopathic generalized epilepsy (IGE) accounts for 20 % of epilepsy cases and has no visible lesions on conventional MRI, making diagnosis difficult. Emerging data suggest that minor subcortical anatomical abnormalities may contribute to seizure generation and propagation, notably in the thalamus and hippocampus. Advanced volumetric MRI techniques are viable for quantifying these changes and understanding IGE's neurobiological underpinnings. Methods An MRI volumetric study looked at subcortical structural anomalies in patients with IGE using high-resolution T1-weighted imaging and FreeSurfer-based segmentation. A group of 134 IGE patients (aged 1–45 years) was recruited from King Saud Medical City in Riyadh, following strict International League Against Epilepsy (ILAE) diagnostic criteria. Volumetric investigations concentrated on the thalamus, caudate, putamen, pallidum, hippocampus, and amygdala, comparing results to normative values, as including a healthy control group was not feasible due to the retrospective design and data availability. The compared results were examined for the associations with age and gender. Results The study discovered significant age-related volumetric changes, particularly in the hippocampus, where abnormalities were found in 100 % of individuals aged 22–43 years, as opposed to 83.3 % in younger cohorts (1–10 years). The thalamus had a bimodal distribution of anomalies, with peaks in the youngest (64.3 %) and oldest age groups. Females had higher abnormality rates in the left caudate (82.1 % vs. 53.8 % in males) and right thalamus (67.9 % vs. 41.0 %), but males had more involvement in the left putamen (80.8 % vs. 39.3 %). Positive correlations were found between age and volumetric changes in the hippocampi and amygdalae (r = 0.285–0.303, ∗p∗ < 0.01), indicating structural deterioration. Conclusion These findings emphasize the role of age and gender in subcortical dysfunction in IGE, with the hippocampus and thalamus emerging as significant areas of focus. The current study enhances understanding of the neuroanatomical foundation of IGE and supports the use of volumetric MRI in diagnostic methodologies. Future studies should investigate longitudinal and molecular causes of these anomalies.

idiopathic generalized epilepsybrain volumetrythalamushippocampus
تصحيحوصول مفتوح2024

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

Frontiers in Pharmacology · مجلد 15 · 1494110-1494110

Breast carcinoma is one of the most frequent malignancies diagnosed globally and the chief cause of mortality among females (Siegel et al., 2021;Mir and Qayoom, 2023). Nearly 30% of all cancer incidences in women are due to breast cancer (Sung et al., 2021). Globally, BC represents recurrent malignancy among women. In 2020, it exceeded lung cancer to become the top reason of cancer incidence worldwide. A total of 2.3 million additional cases were anticipated, accounting for approximately 11.7% of all cancer cases (Hall et al., 1990).Epidemiological studies have revealed that the burden of breast cancer globally is thought to cross nearly 2 million by the year 2030 (Wooster et al., 1994). The primary major gene that was identified to be associated with hereditary BC in 1990 is BRCA1. Additionally, it was identified by employing linkage analysis in families by exploring suggestive pedigrees (Gallanis et al., 2021). Following this, BRCA2 was mapped to chromosome 13 in 1994 (Baldin et al., 1993). An alteration in either BRCA1 or BRCA2 increases susceptibility to cancer risk, especially BC. Metastatic breast cancer remains almost completely incurable, with an average overall survival (OS) of 3 years and a merely 25% 5-year OS (Cardoso et al., 2018;Sofi et al., 2022a).Although there have been significant advances in the strategies for curing breast cancer, the poor prognosis is still a matter of concern (Waks and Winer, 2019;Sofi et al., 2022b;Mir and Haq, 2023a;Qayoom et al., 2023a;Mir and Haq, 2023b). Due to its heterogeneous nature, it becomes hard to access the surviving individuals (Turashvili and Brogi, 2017;Mehraj et al., 2021;Qayoom et al., 2021). Multiple studies on breast cancer previously identified several genes which possess prognostic value. However, the developing field of bioinformatics along with advancing algorithms has provided researchers with the environment to discover potential genes by employing a different approach (Mehraj et al., 2022;Qayoom et al., 2023b;Sofi et al., 2023). The p53 protein has an essential role in prevention of genomic mutation in the body, but this protein is prone to mutations at a higher rate as witnessed in cancers. Moreover, a malfunction is witnessed in approximately all cancers along the p53 pathway. The altered p53 protein not only loses its function but is also susceptible to misfolding and accumulation, ultimately leading to the formation of amyloid aggregates. Protein misfolding and accumulation have a part to play in cancer development. Recognized as the "guardian of the genome," p53 plays a crucial role in preventing genomic mutations. Structurally, p53 represents a tetrameric transcription factor that modulates multiple cellular roles like expression of target genes that lead to apoptosis, repair of DNA, and arrest of the cell cycle in damaged cells in addition to cellular metabolism (Helton and Chen, 2007;Lukin et al., 2015;Mir et al., 2023a). Due to the fact that more than 50% of cancers are caused due to direct point mutations of p53 (Petitjean et al., 2007;Olivier et al., 2010) and the p53 malfunction as seen in aggressive cancer types like gastric cancer (Blanchet et al., 2021); thus, reverting or restoring the normal p53 function is a marked strategy for possible cancer cure (Hong et al., 2014;Bykov et al., 2018;Miller et al., 2020). The levels of P53 are highly modulated through posttranslational alterations and a pivotal modifier modulator mouse double minute 2 homolog (MDM2). However, during cellular stress, there is an inhibition to p53 degradation; in addition, the protein is accumulated in the nucleus (Friedman et al., 1993;Nag et al., 2013;Mir et al., 2022). The same causes target gene upregulation and triggers reaction mechanisms to bypass the multiplication of injured cells (Brooks and Gu, 2010). For example, when DNA damage occurs, p53 may either force the injured cell to be removed or trigger a cell cycle blockage mechanism that allows DNA repair to proceed (Helton and Chen, 2007;Lukin et al., 2015). The studies have revealed that the DNA-binding domain (DBD) of wild-type p53 displays less thermodynamic and kinetic stability (Natan et al., 2011) and several mutations lead to instability, ultimately causing protein unfolding. Cancer cells acquire high amounts of mutant p53 because it avoids the MDM2-mediated proteasomal destruction (Scian et al., 2004).MDM2 has been shown to play a post-ubiquitination function in the degradation of p53 (Kulikov et al., 2010). Aggregation and unfolding are intricate processes; however, destabilization exposes an adhesive sequence that attaches to the same section in other p53 units and triggers aggregation. Consequently, there is significant interest in the creation of novel agents that can both stabilize folded structures and prevent aggregation or split preformed aggregates (Miller et al., 2020;Miller et al., 2022). There are multiple ways through which altered p53 protein can be stabilized in its active and folded form. A comprehensive set of Michael acceptors, including CP-31398 and PRIMA1, has been seen to rectify the native information on mutant p53 and initiate p53-dependent cytotoxicity (Foster et al., 1999;Bykov et al., 2002;Rangel et al., 2019;Mir et al., 2023b). PhiKan-083 represents a small molecule and a carbazole derivative, which binds to the surface cavity and leads to the stabilization of a p53 mutant, namely, Y220C, possessing a Kd of 167 μM. Thus, we attempted to explore PhiKan-083 for breast cancer research. Y220C mutation, which is not involved in DNA interaction, causes a destabilization of the protein. PhiKan-083 binding stabilizes the mutant p53 and slows the rate of denaturation.Hence, for this study, we screened and examined many analogs of PhiKan-083 with better docking scores in comparison to PhiKan-083 for stabilizing misfolded p53. We evaluated the molecule-to-molecule docking of selected compounds to determine the therapeutic potential of screened PhiKan-083-related analogs by calculating the drug-likeliness of those compounds. This work identified two novel compounds that, in addition to their potential as PhiKan-083 substitutes, have advantages such as potential activity against a variety of p53-misfolded malignancies and not just breast cancer. We also looked at p53's expression patterns and predictive values across a range of cancer types, especially breast cancer.UALCAN (http://ualcan.path.uab.edu/) represents a web-based interactive portal to investigate cancer omics data (Chandrashekar et al., 2017). UALCAN has been made to furnish access to publicly available cancer OMICS data easily with the aim of running in silico validation of genes that are of interest or to identify related biomarkers. These databases furnish the graphical representation along with the plots displaying the expression profiles along with the subject survival information. We selected TCGA invasive breast carcinoma data, and P53 expression was examined among different cancer stages, sample types, and sub-classes.TIMER 2.0 (http://timer.comp-genomics.org/) is an instructive tool used to thoroughly evaluate the expression and quantification of immune infiltrates across malignancies. Users can investigate the connection between gene expression and other variables using the database's algorithms, including quanTIseq, CIBERSORT, MCPcounter, and EPIC algorithms; the status of its mutation; and its association with different immune cell kinds. To better comprehend the gene expression profiles of all malignancies, a heatmap of TP53 was created using TIMER 2.0 (Li et al., 2020).Through TCGA and GTEx projects, RNA-sequencing expression data from 9,736 tumors and 8,587 normal samples were analyzed using the web-based application GEPIA2 (http://gepia2.cancer-pku.cn). Subject survival analysis, dimensionality reduction study, identification of related genes, profiling based on cancer types or pathological stages, assessment of differential expression between tumors and normal tissues, and correlation analysis are a few of the resources that can be tailored. By gathering RNA-seq datasets from the UCSC Xena project (http://xena.ucsc.edu), the GEPIA2 followed a pre-established process (Tang et al., 2019). The TP53 expression in varied cancers was obtained by employing the GEPIA2 portal.The breast cancer gene-expressionminer v4.5 (http://bcgenex.ico.unicancer.fr/) is a bioinformatics tool available online that contains published BC transcriptomic and RNA-seq data in an annotated form (Jézéquel et al., 2012;Jezequel et al., 2013). It was employed to analyze the link between p53 expression levels and distinct clinical factors of breast tumor subjects. P53 expression analysis results were analyzed for basal-like luminal A and luminal B types.For researchers who want to carefully examine the functional proteomics of various cancer types, the University of Texas MD Anderson Cancer Center's Cancer Proteome Atlas Portal is a goto source (https://tcpaportal.org/tcpa/). Using the website's database of patient cohorts, the users can search through the datasets of patient tumors that have been obtained and sequenced by the Center. Users can obtain thorough explanations of each dataset and use a network model or heatmap to evaluate the interactions of the proteins in the data. This website offers a database of cancer cell lines in addition to the patient's cohort database, which researchers can browse and analyze.The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), both of which are divisions of the National Institutes of Health of the U.S. Department of Health and Human Services, have collaborated on it (https://portal.gdc.cancer.gov/). A pilot study for the Cancer Genome Atlas was conducted to see whether a larger project must be undertaken to systematically examine every type of genetic mutation connected to human cancer. Next, using matched normal samples, the scientists molecularly defined almost 20,000 initial cancer samples from 33 distinct cancer types. It is open to all members of the scientific community to use the almost 2.5 petabytes of data generated by TCGA.Since 1992, PredictProtein (https://predictprotein.org) has predicted the structure and functional characteristics of proteins using sequence analysis. Multiple sequence alignments anticipated structural elements [solvent accessibility, secondary structure, coiled-coil regions, transmembrane helices (TMSEG) and strands, disulfide bonds, and disordered areas] and functional elements are returned in response to a protein sequence query. Among the analysis techniques included in the service are functional region identification (ConSurf), homologybased inference of GO terms (meta-student), precise subcellular localization prediction (LocTree3), protein-polynucleotide binding sites (SomeNA), protein-polynucleotide binding sites (ISIS2), and predictions of the impact of point mutations (non-synonymous SNPs) on protein function (SNAP2). Their objective has consistently been to provide a tailored solution that satisfies the needs of researchers with less experience in bioinformatics. To achieve this, the PredictProtein results are given as text along with a number of coherent, engaging, and visually appealing images. The sources and web server may be accessed at (http://ppopen.rostlab.org).In this work, PhiKan-083 served as the reference compound, and 100 compounds with similar structural properties were examined. We collected these compounds from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/) and investigated all of the physico-chemical characteristics of the compounds. The specific compounds were analyzed using Discovery Studio v18 after copying them in SDF format (Kim et al., 2019).The retrieved PhiKan-083 analogues were assessed for drug-likeness using Swiss ADME, an online portal that assesses a drug's potential by examining characteristics such as Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of the selected 100 analogues (http://www.swissadme.ch). Numerous parameters, such as hydrogen bond acceptors (nHBAs), the log of the n-octanol/water partition coefficient (LogP), hydrogen bond donors (nHBDs), molecular polar surface area (PSA), molecular weight (MW), and number of rotatable bonds (nRotBs), were calculated by incorporating Lipinski's rule of five and the Veber rule. The ADMET prediction technique took into account a number of parameters, including aqueous solubility, cytochrome P450 (CYP) 2D6 inhibition, hepatotoxicity, intestinal absorption, and plasma protein binding. After being chosen, the compounds that complied with ADMET drug likeliness guidelines underwent molecular docking (Rudrapal et al., 2022).The target protein TP53 (PDB ID 8dc4) was obtained from the Protein Data Bank (PDB) in a PDB format (Kulikov et al., 2010). By removing the extra structural moieties like heteroatoms, water molecules, and any associated ligands, the p53 protein was cleared up for further study using the Discovery studio (Nguyen et al., 2014).To ascertain the ligands' affinities for binding to TP53, the compounds were first exposed to molecular docking after undergoing ADMET analysis. Every ligand was docked with the TP53 protein using Auto Dock v4.2.6. Using the co-crystallized X-ray structure of the p53 protein from the RCSB PDB, the binding cavity was built. The co-crystallized ligand's three spacers' residue locations were computed. Following the selection of a cavity, the energy was reduced by applying conjugate gradient and steepest descent algorithms. By merging the nonpolar hydrogens, the receptor and target molecules were finally stored in pdbqt format. We created grid boxes at 0.3 intervals. The protein-ligand complex was docked using the Lamarckian Genetic Algorithm (LGA) in order to determine the lowest free energy of binding (G). Three similar sets of molecular modeling experiments were carried out, with the default settings being a maximum of 2700 generations, 2,500,000 evaluations, and 50 solutions each set (Qayoom et al., 2022).As shown in the heatmap in Figure 1 A, the TIMER 2.0 analysis of the TP53 expression pattern showed overexpression of TP53 across all TCGA datasets. TP53 levels were further assessed using CPTAC samples from the UALCAN database. When compared to normal samples, it was also discovered that the levels of the protein TP53 were significantly raised in a number Using the web-based Enrichr programme for GO analysis, it was demonstrated that MF was considerably enriched compared to BP and CC. The Figure 3 Using KM-plotter from GEPIA2, the prognostic significance of TP53 was assessed across all cancer types. The relationship between overall survival (OS) and relapse-free survival (RFS) and the median expression of TP53 was investigated. According to the study, reduced overall survival (OS) is associated with elevated TP53 expression in the ACC, BRCA, KIRP, LAML,LGG, LIHC, PRAD, SARC, THCA, and UCS Figure 4. The hazard ratio for all malignancies ranged from 1 to 12, with LIHC having the lowest and PRAD having the highest. High TP53 mRNA levels are linked to worse relapse-free survival (RFS) in LGG, UCS, and BRCA, followed by LAML, SARC, ACC, KIRP, LIHC, PRAD, and THCA according to the connection between TP53 mRNA levels and RFS. These investigations demonstrated the importance of TP53 in cancer prognosis, making it a promising target for treating various malignancies. Using UALCAN database, we analyzed the expression pattern of p53 in breast cancer. The heat map was generated by correlating p53 with other overexpressed genes in BC using correlation coefficient The study showed that among all the genes, p53 was We compared the p53 expression in both normal and tumor samples, p53 was in breast cancer. Using the same database, we also analyzed the expression of p53 among various of BC the major associated with p53 misfolding is due to its point mutation we the sequence of P53 using database to the of the status of It was revealed that p53 protein sequence has higher of structural mutations that have significantly its its tumor protein misfolding is it was further assessed to the of mutations that are or mutations that lead to of tumor It was seen that protein misfolding to the of function potential of P53 protein as is shown in the Figure was revealed from the results that P53 protein expression was highly in several cancers including breast cancer and the misfolding was to its of function tumor development. We further the protein secondary structure using the tool and the functional of point mutations of p53 protein and the of it by a heatmap using as shown in Figure for its potential and higher of cases due to the same In order to 100 molecules that are similar to the PubChem database was Following that, the compounds were examined ADMET analysis. compounds specific drug-likeliness characteristics were from the screened including PhiKan-083 as in Using molecular docking the binding of these compounds with TP53 was further Following ADMET each drug underwent a molecular docking study with the target TP53 activity of the was from the binding of the compounds. According to the study, two with the PubChem and higher binding compared to the reference molecule The TIMER 2.0 analysis of the TP53 expression pattern revealed overexpression of TP53 across all TCGA datasets. TP53 levels were further assessed using CPTAC samples from the UALCAN database. After with normal samples, it was also witnessed that the levels of TP53 protein were significantly elevated in various tumor GEPIA2 database, we further examined the expression pattern of TP53 in several malignancies. These results that TP53 is highly in several malignancies, including BRCA, luminal A, luminal and the it was witnessed that MF was significantly enriched in comparison to BP and through GO analysis. By employing KM-plotter from GEPIA2, the prognostic importance of TP53 was assessed across all cancer types. the study, reduced overall survival (OS) was linked with TP53 expression in the ACC, BRCA, KIRP, LAML, LGG, LIHC, PRAD, SARC, THCA, and TP53 mRNA levels were to worse relapse-free survival (RFS) in LGG, UCS, and BRCA, followed by LAML, SARC, ACC, KIRP, LIHC, PRAD, and THCA as the link between TP53 mRNA levels and RFS. These investigations demonstrated the significance of TP53 in cancer prognosis, it as a promising target for treating various malignancies. UALCAN database, we analyzed the expression pattern of p53 in breast cancer. is the most aggressive of breast cancer, study revealed that among all P53 was in and it was most in the major associated with p53 misfolding is due to its point mutation we examined the sequence of P53 using database to the of the status of It was that protein misfolding to the of function potential of P53 protein. We further the protein secondary structure by exploring the web-based PredictProtein tool and examined the functional of point mutations of p53 protein and its by a heatmap using In order to analyze the 100 molecules that are similar to the PubChem database was Following this, the same compounds were analyzed through ADMET analysis. The top compounds specific drug-likeliness characteristics were from the screened including PhiKan-083 by using the molecular docking the binding of these compounds with TP53 was the we to explore the expression of TP53 in its therapeutic prognostic and the impact of overexpression on overall and relapse-free survival in a range of cancers. We the TP53 expression profiles across all TCGA using the TIMER 2.0 database. When TP53 was compared to normal samples for study of differential it was shown that malignancies such BRCA, and elevated TP53 According to this study, TP53 is a major in a number of making it a TP53 overexpression was shown to be caused by gene alteration and TCGA analysis was used to evaluate this examining the correlation between mRNA expression and survival demonstrated a significant association with many malignancies with elevated hazard study a correlation between high TP53 mRNA levels and poor OS in ACC, BRCA, KIRP, LAML, LGG, LIHC, PRAD, SARC, THCA, and free survival (RFS) has been associated with higher TP53 mRNA levels in KIRP, LIHC, and we the impact of point mutations on p53 protein misfolding using database. The of genetic alteration a role in of of P53 protein. we examined the potential role of a P53 stabilizing and its analogues in breast cancer. We screened 100 analogues to PhiKan-083 and examined them for their drug-likeliness Among those compounds were selected for their drug-likeliness and further investigated molecular docking We two novel compounds and analogues to PhiKan-083 that may be further for their therapeutic potential by P53 misfolding not only for breast cancer but for other as

breast cancerBRCA1BRCA2metastatic breast cancer
مراجعةوصول مفتوح202328استشهاد· Semantic Scholar

Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors

ACS Omega · مجلد 8 (41) · 37731-37751

The monoamine oxidase enzyme (MAO), which is bound on the membrane of mitochondria, catalyzes the oxidative deamination of endogenous and exogenous monoamines, including monoamine neurotransmitters such as serotonin, adrenaline, and dopamine. These enzymes have been proven to play a significant role in neurodegeneration; thus, they have recently been researched as prospective therapeutic targets for neurodegenerative illness treatment and management. MAO inhibitors have already been marketed as neurodegeneration illness treatments despite their substantial side effects. Hence, researchers are concentrating on developing novel molecules with selective and reversible inhibitory properties. Piperine, which is a phytochemical component present in black pepper, has been established as a potent MAO inhibitor. Piperine encompasses a piperidine nucleus with antibacterial, anti-inflammatory, antihypertensive, anticonvulsant, antimalarial, antiviral, and anticancer properties. The current Review focuses on the structural changes and structure-activity relationships of piperidine derivatives as MAO inhibitors.

piperidine derivativesmonoamine oxidase inhibitorspiperinestructure-activity relationship
مقالوصول مفتوح202321استشهاد· Semantic Scholar

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3- d ]pyrimidine derivatives as new EGFR inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry · مجلد 38 (1) · 2220579-2220579

A group of EGFR inhibitors derived from thieno[2,3-d]pyrimidine nucleus was designed, synthesised, and examined as anti-proliferative lead compounds. MCF-7 and A549 cell lines were inhibited by 5b, the most active member. It had inhibitory partialities of 37.19 and 204.10 nM against EGFRWT and EGFRT790M, respectively. Compound 5b was 2.5 times safer against the WI-38 normal cell lines than erlotinib. Also, it demonstrated considerable potentialities for both early and late apoptosis induction in A549. Simultaneously, 5b arrested A549’s growth at G1 and G2/M phases. Harmoniously, 5b upregulated the BAX and downregulated the Bcl-2 genes by 3-fold and increased the BAX/Bcl-2 ratio by 8.3-fold comparing the untreated A549 cells. Molecular docking against EGFRWT and EGFRT790M indicated the correct binding modes. Furthermore, MD simulations confirmed the precise binding of 5b against the EGFR protein over 100 ns. Finally, various computational ADMET studies were carried out and indicated high degrees of drug-likeness and safety.

EGFR inhibitorsthieno[2,3-d]pyrimidine derivativesantiproliferative activityapoptosis
مقالمفتوح (مستودع)202310استشهاد· Semantic Scholar

The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells

Saudi Pharmaceutical Journal · مجلد 31 (12) · 101871-101871

Background: Huntington's disease is an inherited progressive neurodegenerative disorder caused by an expansion of the polyglutamine tract leading to malformation and aggregation of the mutant huntingtin protein in the cell cytoplasm and nucleus of affected brain regions. The development of neuroprotective agents from plants has received considerable research attention. Objective: Our study aims to investigate the neuroprotective effects of luteolin and the mechanisms that underline its potential mediated protection in the mutant htt neuroblastoma cells. Methods: The mutant htt neuroblastoma cells were transfected with 160Q, and the control wild-type neuroblastoma cells were transfected with 20Q htt for 24 h and later treated with luteolin. Cell viability was determined by MTT and PI staining in both groups, while western blotting was used to evaluate caspase 3 protein expression. Aggregation formation was assessed via immunofluorescence microscopy. Also, western blotting was utilized to measure the protein expression of mutant htt aggregated and soluble protein, Nrf2 and HO-1. The impact of Nrf2 on luteolin-treated neuroblastoma cells was assessed using small interfering RNAs. Results: Our study reports that luteolin can protect cultured cells from mutant huntingtin cytotoxicity, evidenced by increased viability and decreased apoptosis. Also, luteolin reduced the accumulation of soluble and insoluble mutant huntingtin aggregates in mutant htt neuroblastoma cells transfected with 160Q compared to the control wild-type. The mutant htt aggregate reduction mediated by luteolin appeared to be independent of the Nrf2 -HO-1 antioxidant pathway. Conclusion: Luteolin presents a new potential therapeutic and protective agent for the treatment and decreasing the cytotoxicity in neurodegenerative diseases such as Huntington's disease.

luteolinHuntington's diseasemutant huntingtinprotein aggregation
مقالمفتوح (مستودع)20235استشهاد· Semantic Scholar

Inhibition of SARS-CoV2 viral infection with natural antiviral plants constituents: An in-silico approach

Journal of King Saud University - Science · مجلد 35 (3) · 102534-102534

Background and Objective: In 2019, a novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) was declared pandemic. Advancement in computational technology has provided rapid and cost-effective techniques to test the efficacy of newer therapeutic agents. This study evaluated some of the potent phytochemicals obtained from AYUSH (Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa, and Homeopathy)-listed medicinal plants against SARS-CoV-2 proteins using computational techniques. Materials and methods: The potential SARS-CoV-2 protein targets were utilized to study the ligand-protein binding characteristics. The bioactive agents were obtained from ashwagandha, liquorice, amla, neem, tinospora, pepper, and stevia. Ivermectin was utilized as a reference agent to compare its efficacy with phytochemicals. Results: The computational analysis suggested that all the bioactive components from the selected plants possessed negative docking scores (ranging from -6.24 to -10.53). The phytoconstituents were well absorbed, distributed in the body except for the CNS, metabolized by liver enzymes, well cleared from the body, and well tolerated. The data suggest that AYUSH-recommended plants demonstrated therapeutic efficacy against SARS CoV-2 virus infection with significantly reduced toxicity. Conclusion: The phytoconstituents were found to hinder the early stages of infection, such as absorption and penetration, while ivermectin prevented the passage of genetic material from the cytoplasm to the nucleus. Additional research involving living tissues and clinical trials are suggested to corroborate the computational findings.

SARS-CoV-2COVID-19 pandemicantiviral phytochemicalsmedicinal plants
مقالوصول مفتوح202295استشهاد· Semantic Scholar

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies

Journal of Enzyme Inhibition and Medicinal Chemistry · مجلد 37 (1) · 1903-1917

A thiazolidine-2,4-dione nucleus was molecularly hybridised with the effective antitumor moieties; 2-oxo-1,2-dihydroquinoline and 2-oxoindoline to obtain new hybrids with potential activity against VEGFR-2. The cytotoxic effects of the synthesised derivatives against Caco-2, HepG-2, and MDA-MB-231 cell lines were investigated. Compound 12a was found to be the most potent candidate against the investigated cell lines with IC50 values of 2, 10, and 40 µM, respectively. Furthermore, the synthesised derivatives were tested in vitro for their VEGFR-2 inhibitory activity showing strong inhibition. Moreover, an in vitro viability study against Vero non-cancerous cell line was investigated and the results reflected a high safety profile of all tested compounds. Compound 12a was further investigated for its apoptotic behaviour by assessing the gene expression of four genes (Bcl2, Bcl-xl, TGF, and Survivin). Molecular dynamic simulations authenticated the high affinity, accurate binding, and perfect dynamics of compound 12a against VEGFR-2.

thiazolidine-2,4-dioneoxindolesVEGFR-2 inhibitorsmolecular hybridization
مقالمفتوح (مستودع)20223استشهاد· Semantic Scholar

Dynamic cytosolic foci of DPPA4 in human pluripotent stem cells

Tissue and Cell · مجلد 78 · 101893-101893

DPPA4 is essential for the pluripotent stem cell state, yet its function is poorly understood. DPPA4 is localized in the nucleus, where it is associated with active chromatin. We now report that it is also present in the cytosol, where it appears as diffused clouds, distinct foci and sometimes as spaghetti-like structures. This cytosolic localization is dynamic and DPPA4 shuttles between the cytosol and the nucleus. Its presence is almost abolished from the nucleus upon differentiation. Co-immunoprecipitation studies highlighted novel protein interactors, many of which are also found in the cytosol and are implicated in mRNA processing and RNA and protein transport between the cytosol and the nucleus. Finally, the depletion of DPPA4 resulted in cytosolic accumulation of vesicles. The cytosolic presence of DPPA4 highlights unexplored research directions that could significantly advance the understanding of DPPA4 in pluripotent stem cells and in cancer.

DPPA4pluripotent stem cellsmRNA processingRNA transport
مقالوصول مغلق20222استشهاد· Semantic Scholar

Plumbagin Attenuates Depression-Like Behavior in Mice by Modulating Dopamine Levels

Current Topics in Nutraceutical Research · مجلد 20M (1) · M6-M10

This research was done to investigate the antidepressant properties of plumbagin using a chronic mild stress induced depression model in experimental animals. Albino mice of either sex were given 3 weeks of chronic mild stress and their antidepressant properties were assessed using the tail suspension test and sucrose preference test. The period of immobility in the tail suspension test and the percentage preference for sucrose solution were both recorded and compared. Plumbagin was given in three doses (4, 8, and 16 mg/kg). The immobility time in the tail suspension test was significantly decreased in the animals that received plumbagin administration during the three phases of the chronic mild stress when compared to control. Further, plumbagin administration dose dependently increased the percentage preference for sucrose solution on par with the standard antidepressant, imipramine. The spontaneous locomotion count was significantly higher in the animals that received a high dose of plumbagin. Further, a high dose of plumbagin significantly reverses the chronic mild stress induced plasma corticosterone and nitrile levels. Additionally, a high level of dopamine was found in the prefrontal and nucleus accumbens parts of the brain. To summarize, plumbagin, in addition to its antioxidant characteristics, has potential antidepressant action at high doses, potentially by raising the dopamine levels.

plumbaginantidepressant effectsdepression-like behaviorchronic mild stress
مقالوصول مفتوح20216استشهاد· Semantic Scholar

Morus alba Prevented the Cyclophosphamide Induced Somatic and Germinal Cell Damage in Male Rats by Ameliorating the Antioxidant Enzyme Levels

Molecules · مجلد 26 (5) · 1266-1266

Cytogenetic analysis is essential to determine the effect of mutagens and antimutagens on genetic material. This study was done to evaluate the protective effect of root bark extract of Morus alba (M. alba) against cyclophosphamide induced somatic and germinal cell damage in male rats. The ethanolic extract of M. alba (0.25, 0.5 and 1 g/kg, 2 weeks) was evaluated against cyclophosphamide (75 mg/kg, single dose) induced nuclear damage. The sampling was done after 48 h of the clastogen treatment. The somatic and germinal nuclear damage was studied by bone marrow micronucleus and sperm analysis, respectively. Serum superoxide and catalase levels were estimated to determine the antioxidant status in each group. The results were analyzed statistically to find the significant variation. The administration of M. alba for 2 weeks suppressed dose-dependently the changes induced by cyclophosphamide. M. alba (0.5 g/kg) decreased the frequency of micronucleated erythrocyte, sperm shape abnormality and enhanced the sperm count, sperm motility and polychromatic-normochromatic erythrocytes ratio significantly (p < 0.05) in comparison with the cyclophosphamide treated group. The highest tested dose of M. alba (1 g/kg) produced more prominent suppression (p < 0.01) in the cyclophosphamide-induced somatic and germinal cell defects. The results also showed significant (p < 0.05) improvement in the serum antioxidant enzymes levels with M. alba when compared with the challenge group. The lower dose of M. alba extract (0.25 g/kg) prevented the CP-induced changes but was found to be statistically insignificant. Therefore, antimutagenic potential of the high dose of the extract of M. alba is possibly due to its antioxidant nature. The ability of the M. alba extract to prevent the nuclear damage could play an important role in overcoming several mutational defects that are associated with anticancer chemotherapy.

Morus albacyclophosphamidemicronucleisperm abnormalities
مقالوصول مفتوح20155استشهاد· Semantic Scholar

“Pyridopyridazine”: A Versatile Nucleus in Pharmaceutical Field

Journal of Biosciences and Medicines · مجلد 03 (10) · 59-66

Pyridopyridazines are an important kind of nitrogen atom containing heterocyclic compounds due to their synthetic and pharmacological versatility. This fused heterocycle system represents a common structural feature for many bioactive compounds showing a variety of pharmacological activities which makes it an attractive scaffold for the design and development of new drugs. This mini review summarizes an updated information described in recent literature, about the most relevant pharmacological properties of pyridopyridazines derivatives.

fused heterocyclesnitrogen heterocyclespharmacological propertiesbioactive compounds